NCT00369304View on ClinicalTrials.gov

Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Healthy Subjects
Interventions
DRUG

pharmacokinetic (how the body absorbs and eliminates) interaction

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00369304 - Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate | Biotech Hunter | Biotech Hunter